FDA Drug Application (021290) for TRACLEER by ACTELION PHARMS LTD

Back to FDA Applications sponsored by ACTELION PHARMS LTD

Application Number021290
Product Number001
FormTABLET;ORAL
Dosage62.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTRACLEER
Active IngredientBOSENTAN



Back to FDA Applications sponsored by ACTELION PHARMS LTD